文献速递生殖医学

孕前抗苗勒管激素水平不影响多囊卵巢综合征女性的围产结局

Prepregnancy levels of antimüllerian hormone do not impact the perinatal outcomes in women with polycystic ovary syndrome.
PubMed 文献 · Fertil Steril · 2025-06-25

本回顾性队列纳入2016年1月至2023年6月间接受新鲜或冷冻胚胎移植并首次单胎活产的1952例多囊卵巢综合征女性,按孕前血清抗苗勒管激素(AMH)水平分为低(≤6.54 ng/mL)、平均(>6.54且≤14.53 ng/mL)、高(>14.53 ng/mL)三组。调整混杂因素后,AMH作为连续或分类变量均与早产、低出生体重、巨大儿、小于胎龄儿、大于胎龄儿及妊娠相关并发症无显著关联,限制性立方样条未见非线性关系,新鲜与冷冻周期分别分析及按体重指数和年轻女性亚组分析结论一致。

要点

  • PCOS女性孕前高血清基础AMH水平者围产结局仍满意。
  • AMH作为连续或分类变量均与所研究的围产结局无显著关联。
  • 体外受精管理决策应更多依据既定产科指标而非仅凭AMH水平。

核心结论

  • PCOS患者孕前高血清基础AMH水平者围产结局仍满意,体外受精管理决策应更多依赖既定产科指标而非仅凭AMH水平。

研究设计与样本

  • 回顾性队列研究,纳入2016年1月至2023年6月期间接受新鲜或冷冻胚胎移植并成功获得首次单胎活产的1952例多囊卵巢综合征女性。

主要发现

  • AMH作为连续或分类变量,调整潜在混杂因素后与任何围产结局均无显著关联。
  • 限制性立方样条曲线分析未发现非线性关系。
  • 早产患者的AMH分布与足月分娩患者相似,证实早产风险与AMH水平无关。
  • 进一步分析冷冻和新鲜周期均未发现AMH水平与各种异常围产结局(包括早产)之间存在关联。
  • 基于不同体重指数分类和年轻女性的亚组分析得出了一致结论。

关键数值与推荐

  • AMH低水平组:AMH≤第25百分位/6.54 ng/mL。
  • AMH平均水平组:AMH>第25百分位/6.54 ng/mL且≤第75百分位/14.53 ng/mL。
  • AMH高水平组:AMH>第75百分位/14.53 ng/mL。

临床怎么用

  • 原文结论指出,体外受精管理决策应更多依赖既定产科指标而非仅凭AMH水平。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the relationship between prepregnancy serum antimüllerian hormone (AMH) levels and perinatal outcomes in women with polycystic ovary syndrome (PCOS) undergoing fresh or frozen embryo transfer (ET) cycles. DESIGN: Retrospective cohort study. SUBJECTS: The study retrospectively included 1,952 women with PCOS who received fresh or frozen ET cycles and successfully achieved their first single live birth between January 2016 and June 2023. EXPOSURE: The levels of AMH were measured. Patients were classified into three categories according to their AMH levels: the low-level category (AMH level ≤25th percentile/6.54 ng/mL), the average-level category (AMH level between >25th percentile/6.54 ng/mL and ≤75th percentile/14.53 ng/mL), and the high-level category (AMH level >75th percentile/14.53 ng/mL). Multivariate regression analyses were performed to examine the association between AMH levels, treated as either a continuous or categorical variable, and perinatal outcomes after controlling for confounders. Restricted cubic spline curve analysis was performed to assess potential nonlinear relationships. Separate analyses were conducted for fresh and frozen ET cycles. MAIN OUTCOME MEASURES: Preterm birth, low birth weight, macrosomia, small for gestational age, large for gestational age, and pregnancy-related complications. RESULTS: When analyzed as either a continuous or categorical variable, AMH levels exhibited no significant association with any perinatal outcomes after adjusting for potential confounders. Restricted cubic spline curve analysis revealed no nonlinear relationships. The distribution of AMH in patients with preterm birth was similar to that of patients with term delivery, confirming that the risk of preterm birth is not linked to AMH levels. Further analysis of both frozen and fresh cycles revealed no association between AMH levels and various abnormal perinatal outcomes, including preterm birth. Subgroup analyses on the basis of different body mass index categories and young women yielded consistent conclusions. CONCLUSION: Patients with PCOS with high serum basal AMH levels still have satisfactory perinatal outcomes. In vitro fertilization management decisions should rely more on established obstetric indicators rather than AMH levels alone.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Guo Y, Chen H, Zha L, et al. Prepregnancy levels of antimüllerian hormone do not impact the perinatal outcomes in women with polycystic ovary syndrome. Fertil Steril. 2025. PMID: 40578662. doi:10.1016/j.fertnstert.2025.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。